Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Prevention of post-operative pelvic bleeding and collection after sphincter-saving surgery for rectal cancer using a calcium-alginate haemostatic

ABSTRACT: Study hypothesis: Assess the possible benefit of Hemoionic, a new haemostatic, in sphincter-saving surgery for rectal cancer with special reference to pelvic fluid collection reduction. Primary outcome(s): Volume of fluid collected by the pelvic suction drain.

DISEASE(S): Rectal Cancer/colorectal Surgery

PROVIDER: 2423965 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Drain Fluid Amylase as an early biomarker of anastomotic leak in low colorectal anastomoses

Project description:Interventions: Measure amylase levels in drain fluid daily after low colorectal anastomoses as an early indicator of anastomotic leak. - a small sample of drain fluid will be collected daily while pelvic drain is in situ during hospital admission following colorectal surgery and samples will be sent to the local pathology service for measurement of amylase - the amylase levels in drain fluid at each collection while the drain is in-situ will be collected and correlated to the clinical course - clinical course following surgery will be observed during admission (and data collected after patient has been discharged, retrospective data collection). - Follow up consultation at 6 weeks following surgery Primary outcome(s): Daily amylase levels in the drain fluid post-operatively. The measurement of amylase in drain fluid is measured and reported by local pathology service.[Day 1, Day 2, Day 3, Day 4 and Day 5, post operatively, or until pelvic drain is removed. ] Study Design: Purpose: Screening;Duration: Longitudinal;Selection: Defined population;Timing: Both

| 2471651 | ecrin-mdr-crc

ChIP-seq from gastroesophageal sphincter (ENCSR483GTS)

Project description:ChIP-seq on human gastroesophageal sphincter For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-10-23 | GSE105701 | GEO

ChIP-seq from gastroesophageal sphincter (ENCSR372QOY)

2017-10-23 | GSE105593 | GEO

ChIP-seq from gastroesophageal sphincter (ENCSR414TPL)

Project description:POLR2A ChIP-seq on human gastroesophageal sphincter For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-10-23 | GSE105483 | GEO

ChIP-seq from gastroesophageal sphincter (ENCSR091CSG)

2017-10-20 | GSE105245 | GEO

ChIP-seq from gastroesophageal sphincter (ENCSR186NVR)

Project description:CTCF ChIP-seq on human gastroesophageal sphincter For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-10-20 | GSE105372 | GEO

ChIP-seq from gastroesophageal sphincter (ENCSR661XNQ)

2017-10-23 | GSE105609 | GEO

Single cell RNA-sequencing reveals molecular signatures that distinguish allergic from irritant contact dermatitis

Project description:Allergic and irritant contact dermatitis can be challenging to distinguish. We used single cell RNA sequencing (scRNA-seq) and insterstitial fluid proteomic analysis to compare suction blister biopsy skin samples from human volunteers with induced allergic and irritant contact dermatitis reactions.

2024-09-15 | GSE267929 | GEO

Role of differentially expressed microRNA-139-5p in the regulation of phenotypic internal anal sphincter smooth muscle tone

Project description:The present study focused on establishing the role of microRNA-139-5p (miRNA-139-5p) in the phenotypic expression of basal tone in rat internal anal sphincter (IAS) vs. lack of tone in truly phasic smooth muscle of anococcygeus (ASM), via RhoA-associated kinase (RhoA/ROCK2).

2017-06-12 | GSE90981 | GEO

Combined chemio-radioterapy regimen of 5-FU plus irinotecan followed by chemotherapy for the treatment of colorectal cancer with resectable metastases at diagnosis

Project description:Primary objectives: response rate 1. primitive tumor downstagining 2. sphincter-saving 3. synchronous metasteses response

| 2522774 | ecrin-mdr-crc